These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 6610479)
1. Lymphokine regulation of human lymphocyte proliferation: formation of resting G0 cells by removal of interleukin 2 in cultures of proliferating T lymphocytes. Bettens F; Kristensen F; Walker C; Bonnard GD; de Weck AL Cell Immunol; 1984 Jul; 86(2):337-46. PubMed ID: 6610479 [TBL] [Abstract][Full Text] [Related]
2. Effect of camptothecin on mitogenic stimulation of human lymphocytes: involvement of DNA topoisomerase I in cell transition from G0 to G1 phase of the cell cycle and in DNA replication. Bruno S; Giaretti W; Darzynkiewicz Z J Cell Physiol; 1992 Jun; 151(3):478-86. PubMed ID: 1338332 [TBL] [Abstract][Full Text] [Related]
3. Lymphokine regulation of activated (G1) lymphocytes. II. Glucocorticoid and anti-Tac-induced inhibition of human T lymphocyte proliferation. Bettens F; Kristensen F; Walker C; Schwuléra U; Bonnard GD; de Weck AL J Immunol; 1984 Jan; 132(1):261-5. PubMed ID: 6606667 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies that inhibit activation and proliferation of lymphocytes. II. Requisite role of the monoclonal antibody-defined antigen systems in activation and proliferation of human and rat lymphocytes. Yagita H; Hashimoto Y J Immunol; 1986 Mar; 136(6):2062-8. PubMed ID: 2419421 [TBL] [Abstract][Full Text] [Related]
5. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation. Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412 [TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes. Kurki P; Lotz M; Ogata K; Tan EM J Immunol; 1987 Jun; 138(12):4114-20. PubMed ID: 2884260 [TBL] [Abstract][Full Text] [Related]
7. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells. Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419 [TBL] [Abstract][Full Text] [Related]
8. Effects of benzo[a]pyrene on concanavalin A-stimulated human peripheral blood mononuclear cells in vitro: inhibition of proliferation but no effect on parameters related to the G1 phase of the cell cycle. Mudzinski SP Toxicol Appl Pharmacol; 1993 Apr; 119(2):166-74. PubMed ID: 8097600 [TBL] [Abstract][Full Text] [Related]
9. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies. Tadmori W; Reed JC; Nowell PC; Kamoun M J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919 [TBL] [Abstract][Full Text] [Related]
10. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen. Lazarovits AI; Moscicki RA; Kurnick JT; Camerini D; Bhan AK; Baird LG; Erikson M; Colvin RB J Immunol; 1984 Oct; 133(4):1857-62. PubMed ID: 6088627 [TBL] [Abstract][Full Text] [Related]
11. Desferoxamine blocks IL 2 receptor expression on human T lymphocytes. Carotenuto P; Pontesilli O; Cambier JC; Hayward AR J Immunol; 1986 Apr; 136(7):2342-7. PubMed ID: 3005409 [TBL] [Abstract][Full Text] [Related]
12. Human lymphocyte proliferation. II. Formation of activated (G1) cells. Bettens F; Kristensen F; Walker C; de Weck AL Eur J Immunol; 1982 Nov; 12(11):948-52. PubMed ID: 6983969 [TBL] [Abstract][Full Text] [Related]
13. Dual-parameter flow cytometric analysis of an early lymphocyte activation antigen (CK226) and DNA content. Zocchi MR; Heltai S; Poggi A Cytometry; 1989 Nov; 10(6):762-71. PubMed ID: 2582967 [TBL] [Abstract][Full Text] [Related]
14. Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes. Davis L; Lipsky PE J Immunol; 1986 May; 136(10):3588-96. PubMed ID: 3486215 [TBL] [Abstract][Full Text] [Related]
15. Human lymphocyte proliferation. I. Correlation between activated and proliferating T-lymphocytes. Kristensen F; Walker C; Joncourt F; Bettens F; de Weck AL Immunol Lett; 1982 Aug; 5(2):59-63. PubMed ID: 6984008 [TBL] [Abstract][Full Text] [Related]
16. IL-2-induced expression of TTK, a serine, threonine, tyrosine kinase, correlates with cell cycle progression. Schmandt R; Hill M; Amendola A; Mills GB; Hogg D J Immunol; 1994 Jan; 152(1):96-105. PubMed ID: 8254211 [TBL] [Abstract][Full Text] [Related]
17. Molecular signals in B cell activation. II. IL-2-mediated signals are required in late G1 for transition to S phase after ionomycin and PMA treatment. Lagoo A; Tseng CK; Sell S Cell Immunol; 1990 May; 127(2):497-505. PubMed ID: 2328536 [TBL] [Abstract][Full Text] [Related]
18. Monocyte-independent interleukin-2 production and proliferation of human T cells in response to murine hybridomas expressing the OKT3 monoclonal antibody: interleukin-1 is not required for T-cell proliferation. Itoh K; Balch CM; Platsoucas CD Cell Immunol; 1988 Aug; 115(1):36-56. PubMed ID: 2969776 [TBL] [Abstract][Full Text] [Related]
19. Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes. Welte K; Andreeff M; Platzer E; Holloway K; Rubin BY; Moore MA; Mertelsmann R J Exp Med; 1984 Nov; 160(5):1390-403. PubMed ID: 6092510 [TBL] [Abstract][Full Text] [Related]
20. Human T lymphocyte activation by monoclonal antibodies; OKT3, but not UCHT1, triggers mitogenesis via an interleukin 2-dependent mechanism. Van Wauwe JP; Goossens JG; Beverley PC J Immunol; 1984 Jul; 133(1):129-32. PubMed ID: 6327822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]